Table 2

In Situ Phenotype of DCs in Breast Carcinoma Tissue

PatientCD1aDCGM4CD83CD11cHLA-DRCD80CD86
120130451526
2101438722032
31720824141125
430040512426
540224402022
6631150801514
71811217521320
810030401436
92071214914
108135242247
1164455451826
12113060582623
132212960817
1412703042916
157525032820
16113145501340
1748121039532742
1830322853632237
194117752593243
20100024221510
2132045502514
2260240121822
23100835201515
24701250201526
2511540301811
26401525251523
271810120302016
284510635402632
2953358522032
3021268711824
312115046382014
322817150492932
Mean ± SD12 ± 136 ± 85 ± 639 ± 1442 ± 1818 ± 724 ± 10
  • Values represent the number of cells labeled with antibody recognizing an indicated marker/high power field.